FPMI Financials: FluoroPharma Medical Inc AI Analysis

Home

Stock

FPMI

Financials

FPMI Financial

FluoroPharma Medical Inc

At close: Mar 25, 16:00:00 GMT-4

Pre-market: Mar 26, 08:29:30 GMT-4

Overview Forecast Earnings Dividends Financials

Key Stats

Prev.Close

$0.0002

Open

$0.0001

Day's Range

$0.0001 - $0.0002

52 week range

$0.0001 - $0.0002

Volume

1.1M

Avg.Volume

5.2K

Dividend yield

EPS (TTM)

-0.07

Market Cap

$6.8K

What is FPMI?

FluoroPharma Medical, Inc. engages in the discovery, development, and commercialization of proprietary medical diagnostic imaging products. The company is headquartered in Montclair, New Jersey and currently employs 4 full-time employees. The company went IPO on 2008-08-18. The firm is focused on the development of cardiovascular imaging agents that detect and assess acute and chronic forms of coronary artery disease (CAD). The company has two clinical-stage molecular imaging pharmaceutical product candidates: 18-F TPP (BFPET) and 18-F FCPHA (CardioPET). BFPET program employs a (18F)-labeled cationic lipophilic tetraphenylphosphonium ion as an imaging agent designed for use in stress-testing for patients with presumptive or proven CAD. The company measures the extent and severity of cardiovascular disease through the detection of ischemic and infarcted myocardial tissue. CardioPET program employs Trans-9-(18F)-Fluoro-3, 4-Methyleneheptadecanoic Acid as a molecular imaging agent designed to assess myocardial blood flow and metabolism in patients with CAD.



Features

AI Copilot for Stock & Crypto

Resources

Market

Income

Balance sheet

Cash flow

Annual

Quarterly

FPMI Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	12/31/2016	12/31/2015	12/31/2014	12/31/2013	12/31/2012
Revenue	0	0	0	0	0	0
Revenue Growth (YoY)	--	--	--	--	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	1	1	2	3	3	2
Research & Development	0	0	0	1	1	1
Operating Expenses	2	2	3	5	4	4
Other Non Operating Income (Expenses)	0	0	0	0	0	0
Pretax Income	-2	-2	-3	-4	-5	-4
Income Tax Expense	--	--	0	0	0	0
Net Income	-2	-2	-3	-4	-7	-4
Net Income Growth	-33%	-33%	-25%	-43%	75%	0%
Shares Outstanding (Diluted)	34.02	33.55	30.03	28.64	24.37	22.64
Shares Change (YoY)	8%	12%	5%	18%	8%	28%
EPS (Diluted)	-0.08	-0.07	-0.12	-0.16	-0.29	-0.18
EPS Growth	-28.99%	-38%	-24%	-45%	62%	-23%
Free Cash Flow	0	0	-2	-3	-3	-3
Free Cash Flow Per Share	--	--	--	--	--	--
Gross Margin	--	--	--	--	--	--
Operating Margin	0%	0%	0%	0%	0%	0%
Profit Margin	0%	0%	0%	0%	0%	0%
Free Cash Flow Margin	0%	0%	0%	0%	0%	0%
EBITDA	-2	-2	-3	-5	-4	-4
EBITDA Margin	0%	0%	0%	0%	0%	0%
D&A For EBITDA	0	0	0	0	0	0
EBIT	-2	-2	-3	-5	-4	-4
EBIT Margin	0%	0%	0%	0%	0%	0%
Effective Tax Rate	--	--	0%	0%	0%	0%

Follow-Up Questions

What are FluoroPharma Medical Inc's key financial statements?



According to the latest financial statement (Form-10K), FluoroPharma Medical Inc has a total asset of $0, Net loss of $-2

What are the key financial ratios for FPMI?



FluoroPharma Medical Inc's Current ratio is 0, has a Net margin is 0, sales per share of $0.

How is FluoroPharma Medical Inc's revenue broken down by segment or geography?



FluoroPharma Medical Inc largest revenue segment is Concession, at a revenue of 13,925,711,000 in the most earnings release.For geography, Mexico is the primary market for FluoroPharma Medical Inc, at a revenue of 15,531,860,000.

Is FluoroPharma Medical Inc profitable?



no, according to the latest financial statements, FluoroPharma Medical Inc has a net loss of $-2

Does FluoroPharma Medical Inc have any liabilities?



yes, FluoroPharma Medical Inc has liability of 10

How many outstanding shares for FluoroPharma Medical Inc?



FluoroPharma Medical Inc has a total outstanding shares of 34.07

FluoroPharma Medical Inc (FPMI) Financial

FPMI Stock Price Chart